Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Klara Szalontai"'
Autor:
Jozsef Lazar, Peter Antal-Szalmas, Istvan Kurucz, Annamaria Ferenczi, Mihaly Jozsi, Ilona Tornyi, Monika Muller, Janos Tibor Fekete, John Lamont, Peter FitzGerald, Anna Gall-Debreceni, Janos Kadas, Andras Vida, Nadege Tardieu, Yann Kieffer, Anne Jullien, Mariana Guergova-Kuras, William Hempel, Andras Kovacs, Tamas Kardos, Nora Bittner, Eszter Csanky, Maria Szilasi, Gyorgy Losonczy, Klara Szondy, Gabriella Galffy, Edit Csada, Klara Szalontai, Attila Somfay, David Malka, Paul Cottu, Krisztina Bogos, Laszlo Takacs
Publikováno v:
Molecular & Cellular Proteomics. :100580
Autor:
Patrícia Neuperger, Klára Szalontai, Nikolett Gémes, József Á. Balog, László Tiszlavicz, József Furák, György Lázár, László G. Puskás, Gábor J. Szebeni
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionThe effect of platinum-based chemotherapy (Chem.) and second- or multiple- line immune checkpoint PD-1 blocking therapy by Nivolumab or Pembrolizumab (ICI) was assayed in the peripheral blood of non-small cell lung cancer (NSCLC) patients
Externí odkaz:
https://doaj.org/article/f514d9e1f3a44074afa95d41b6bf325d
Autor:
Patrícia Neuperger, József Á. Balog, László Tiszlavicz, József Furák, Nikolett Gémes, Edit Kotogány, Klára Szalontai, László G. Puskás, Gábor J. Szebeni
Publikováno v:
Cancers, Vol 14, Iss 1, p 144 (2021)
Intratumoral heterogeneity (ITH) is responsible for the majority of difficulties encountered in the treatment of lung-cancer patients. Therefore, the heterogeneity of NSCLC cell lines and primary lung adenocarcinoma was investigated by single-cell ma
Externí odkaz:
https://doaj.org/article/18f30d1ac4ec4d0b89d4cdebb7ad4c8d
Autor:
Klára Szalontai, Nikolett Gémes, József Furák, Tünde Varga, Patrícia Neuperger, József Á. Balog, László G. Puskás, Gábor J. Szebeni
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 13, p 2889 (2021)
Chronic obstructive pulmonary disease (COPD), the frequently fatal pathology of the respiratory tract, accounts for half a billion cases globally. COPD manifests via chronic inflammatory response to irritants, frequently to tobacco smoke. The progres
Externí odkaz:
https://doaj.org/article/8144b41aca7147328250851e16ae8cb7